News and Features | Overview
16th Perl-UNC Neuroscience Prize Recipient - Christopher Walsh
The UNC School of Medicine has awarded the 16th Perl-UNC Neuroscience Prize to Christopher A. Walsh, MD, PhD, Chief of the Division of Genetics and Genomics at Boston Children’s Hospital and Bullard Professor of Pediatrics and Neurology at Harvard Medical School, for the “discovery of genes and mechanisms regulating human cortical development.” Click here to read more.
The Surprising Genealogy of Your Brain
Each of your neurons is more closely related to heart cells than to most of its neighbors. Why?
2015 HMS Student Award Winners
Two students mentored by Genetics and Genomics Division chief, Christopher Walsh, have recently completed their PhD’s and were given prestigious research awards and recognition at this year's Harvard Medical School graduation.
Gilad Evrony: co-winner of the Dr. Sirgay Sanger Award for her work in psychiatry on neuroscience
Yawei Yang: winner of the James Tolbert Shipley Prize for an outstanding published research
Great job and congratulations Gilad and Yawei!
"Medical Minutes" with Dr. Murray Feingold - WBZ NewsRadio 1030
Dr. Murray Feingold, has been a long-time contributor to WBZ ‘s television and radio programs for over 30 years. Currently he does the “Medical Minute” on WBZ NewsRadio 1030. Medical Minutes can be found on the Medical Minutes section of the WBZRadio website.
We have a $1,000 genome. Now what?
How do we go about making clinical genomics an everyday thing?
Genetic signatures yield a blood test for autism
Activity of a group of 55 genes creates a “signature” that correctly identified or ruled out autism in 76 percent of samples tested. The test has been licensed and is being developed by SynapDx(Southborough, Mass.).
Using DNA sequencing in medicine: The international CLARITY challenge
While we have advanced DNA sequencing technology, how do we make the results relevant and useful?
Direct-to-consumer genetic testing: A case of potential harm
A case report flags potential pitfalls in test interpretation.
Duchenne muscular dystrophy: The decade of therapy
Today, a variety of approaches that attempt to either restore dystrophin or compensate for its loss are in the clinical pipeline, says Louis Kunkel, PhD, who identified dystrophin in 1987. Kunkel has established a collaboration with Pfizer to develop new therapeutics.
Read more news and features on the Division of Genetics & Genomics site.